Alison Bauerlein is Director of Pear Therapeutics, Inc.. Currently has a direct ownership of 71,428 shares of PEAR, which is worth approximately $714. The most recent transaction as insider was on Feb 15, 2023, when has been sold 71,428 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 71.4K
0% 3M change
0% 12M change
Total Value Held $714

Alison Bauerlein Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 15 2023
BUY
Grant, award, or other acquisition
-
71,428 Added 50.0%
71,428 Class A Common Stock

Also insider at

INGN
Inogen Inc Healthcare
SGHT
Sight Sciences, Inc. Healthcare
GLS
GELESIS HOLDINGS, INC. Healthcare
AB

Alison Bauerlein

Director
Goleta, CA

Track Institutional and Insider Activities on PEAR

Follow Pear Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PEAR shares.

Notify only if

Insider Trading

Get notified when an Pear Therapeutics, Inc. insider buys or sells PEAR shares.

Notify only if

News

Receive news related to Pear Therapeutics, Inc.

Track Activities on PEAR